• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Calcium/calmodulin-dependent protein kinase type 1B (PNCK)

ACP16122

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16122 Target NamePNCK
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-343Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6P2M8
Background Information
  • Uniprot Id

    Q6P2M8

  • Target Species

    Human

  • Target Name

    PNCK

  • Target Full Name

    Calcium/calmodulin-dependent protein kinase type 1B

  • Target Function

    Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. In vitro phosphorylates CREB1 and SYN1/synapsin I. Phosphorylates and activates CAMK1.

  • Target Subcellular Location

    Cytoplasm. Nucleus.

  • Target Protein Families

    Protein kinase superfamily, CAMK Ser/Thr protein kinase family, CaMK subfamily

  • Target Synonyms

    Calcium/calmodulin dependent protein kinase type 1B ; Calcium/calmodulin-dependent protein kinase type 1B; CaM KI beta; CaM kinase I beta; CaM kinase IB; CaM-KI beta; CaMK1b ; CaMKI beta; CaMKI-beta; EC 2.7.11.17; KCC1B_HUMAN; MGC45419 ; PNCK; Pregnancy up regulated non ubiquitously expressed CaM kinase; Pregnancy up-regulated non-ubiquitously-expressed CaM kinase

Inquire Recombinant Human Calcium/calmodulin-dependent protein kinase type 1B (PNCK) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification